Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment.

Citation: Li C, Yang X, Luo Y, Liu H, Zhong X, Zhou X, Zeng T, Tao L, Zhou Y, Gou K, Yang X, Liu X, Chen Q, Zhao Y, Luo Y.: Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment. J Med Chem, Volume 64 (24), 2021
Authors: Chen Q, Gou K, Li C, Liu H, Liu X, Luo Y, Luo Y., Tao L, Yang X, Zeng T, Zhao Y, Zhong X, Zhou X, Zhou Y
Journal: J Med Chem
Year: 2021
DOI: 10.1021/acs.jmedchem.1c01711
PubMed: 34905371
Machine-readable: REST API RDF

Publication